|
|
CytonomeST Appoints World-Renowned Biological Scientist as Chief Scientific Officer
Boston, MA, March 1, 2009- CytonomeST., developer of the clinical-grade, Gigasort™ optical cell sorter, today announced that Dr. Lydia Villa-Komaroff has been appointed Chief Scientific Officer at CytonomeST.
During her 20 year research career, Dr. Villa-Komaroff has held scientific positions at MIT, Harvard University, University of Massachusetts Medical School and Harvard Medical School. As a science administrator, she was held senior posts including VP for Research at Northwestern University in Chicago along with Vice President for Research & Chief Operating Officer of Whitehead Institute for Biomedical Research in Cambridge, MA. She also chaired the Board of Directors of Transkaryotic Therapies.
“We are extremely pleased to have Dr. Villa-Komaroff lead our new biological science group. Her leadership and proven abilities in managing advanced scientific initiatives is simply outstanding,” said John Sharpe, Ph.D., Chief Executive Officer of CytonomeST. Dr. Villa-Komaroff stated “The founders and employees of CytonomeST have developed technology which will transform the science of cellular medicine. I look forward to working with our collaborators to develop new cellular therapy treatments for currently intractable diseases.”
About CytonomeST
CytonomeST, Inc. develops, manufactures and markets clinical optical cell sorting technology. CytonomeST's Gigasort system is the only clinical-grade optical cell sorter using a sterile, disposable cartridge for precise and safe selection of discrete cell populations. Our revolutionary technologies are used to translate cellular therapies from laboratory to clinic.
For additional information on CytonomeST, please visit the Company’s website at www.CytonomeST.com.
|
